Roy M Gulick Selected Research

Roy M Gulick Research Topics

Disease

37	Acquired Immunodeficiency Syndrome (AIDS) 01/2021 - 07/2002
19	Infections 01/2019 - 01/2002
16	HIV Infections (HIV Infection) 01/2022 - 01/2002
4	COVID-19 10/2022 - 01/2020
4	Viremia 01/2019 - 11/2003
3	Disease Progression 05/2011 - 03/2007
2	Hepatitis B 01/2018 - 12/2005
2	Insulin Resistance 05/2011 - 04/2007
2	Sexually Transmitted Diseases (Sexually Transmitted Disease) 11/2006 - 01/2002
1	Coronavirus Infections 10/2022
1	Injection Site Reaction 12/2021
1	Thrombosis (Thrombus) 01/2021
1	Rheumatic Diseases (Rheumatism) 01/2021
1	Diarrhea 01/2020
1	Vomiting 01/2020
1	Aspergillosis 09/2016
1	Sinusitis 09/2016
1	Hepatitis C 12/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2011
1	Virus Diseases (Viral Diseases) 12/2010
1	Tuberculosis (Tuberculoses) 07/2010
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2010
1	Proteinuria 08/2009
1	Epstein-Barr Virus Infections 03/2009
1	Lymphoma (Lymphomas) 03/2009
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2009
1	Hodgkin Disease (Hodgkin's Disease) 03/2009
1	Neoplasms (Cancer) 07/2007
1	Lipodystrophy 12/2005
1	Hepatitis 12/2005
1	Fatty Liver 12/2005

Drug/Important Bio-Agent (IBA)

19	efavirenz (Sustiva)FDA Link 01/2018 - 04/2004
10	RNA (Ribonucleic Acid)IBA 01/2019 - 08/2006
7	Maraviroc FDA Link 01/2022 - 10/2008
7	NucleosidesIBA 01/2020 - 07/2002
7	Lamivudine (Epivir)FDA Link 01/2019 - 07/2002
6	abacavir (Ziagen)FDA Link 02/2015 - 04/2004
6	vicrivirocIBA 08/2010 - 02/2007
5	Reverse Transcriptase InhibitorsIBA 01/2020 - 04/2004
4	Zidovudine (Retrovir)FDA LinkGeneric 04/2007 - 07/2002
3	Tenofovir (Viread)FDA Link 01/2022 - 02/2019
3	Emtricitabine (Emtriva)FDA Link 01/2022 - 02/2019
3	Protease Inhibitors (Protease Inhibitor)IBA 01/2020 - 04/2004
3	dolutegravirIBA 01/2019 - 03/2016
3	AntibodiesIBA 11/2018 - 01/2015
3	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 03/2009
3	Saquinavir (Invirase)FDA Link 11/2005 - 09/2002
3	Indinavir (Crixivan)FDA Link 04/2004 - 09/2002
2	RacivirIBA 12/2021 - 01/2018
2	IntegrasesIBA 12/2021 - 01/2018
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021 - 01/2020
2	Raltegravir Potassium FDA Link 02/2019 - 04/2009
2	Ritonavir (Norvir)FDA Link 02/2019 - 04/2004
2	Anti-Retroviral Agents (Antiretroviral Agents)IBA 11/2018 - 06/2004
2	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 12/2012 - 09/2010
2	LipidsIBA 05/2011 - 04/2007
2	HDL CholesterolIBA 04/2007 - 12/2005
1	lopinavir-ritonavir drug combination (Kaletra)FDA Link 10/2022
1	cabotegravirIBA 12/2021
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Thromboplastin (Tissue Factor)IBA 01/2021
1	theasinensin AIBA 01/2021
1	Prothrombin (Factor II)IBA 01/2021
1	Integrase InhibitorsIBA 01/2020
1	Atazanavir Sulfate (Reyataz)FDA Link 02/2019
1	Darunavir (Prezista)FDA Link 02/2019
1	Illicit Drugs (Recreational Drugs)IBA 02/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	boldenone undecylenate (Equipoise)IBA 01/2019
1	fibrin fragment D (D-dimer)IBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2018
1	Peptide Hydrolases (Proteases)FDA Link 01/2018
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2018
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2018
1	Polysaccharides (Glycans)IBA 02/2017
1	Immunologic Factors (Immunomodulators)IBA 09/2016
1	Lopinavir FDA Link 11/2011
1	C-Reactive ProteinIBA 05/2011
1	Peptides (Polypeptides)IBA 12/2010
1	Proteins (Proteins, Gene)FDA Link 12/2010
1	Amino Acids FDA Link 12/2010
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2010
1	Cytochrome P-450 CYP3AIBA 09/2010
1	Nevirapine (Viramune)FDA Link 03/2010
1	CreatinineIBA 08/2009
1	AntigensIBA 03/2009
1	oxidized low density lipoproteinIBA 04/2007
1	LDL CholesterolIBA 04/2007
1	Glucose (Dextrose)FDA LinkGeneric 04/2007
1	Triglycerides (Triacylglycerol)IBA 04/2007
1	CholesterolIBA 04/2007
1	ChemokinesIBA 02/2007
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 12/2005

Therapy/Procedure

18	Therapeutics 01/2021 - 01/2002
6	Art Therapy 11/2018 - 06/2004
2	Salvage Therapy 09/2002 - 01/2002
1	Injections 12/2021
1	Immunotherapy 01/2015
1	Aftercare (After-Treatment) 02/2006